Francesco Filippini

Prof. Francesco Filippini

Dipartimento di Biologia, Universita degli Studi di Padova, Padua, Italy
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SMSonia Martinez-Arca
Sonia Martinez-Arca
RRRachel Rudge
Rachel Rudge
Marcella VaccaMarcella Vacca
Marcella Vacca
GRGraça Raposo
Graça Raposo
JCJacques Camonis
Jacques Camonis
Thierry GALLIThierry GALLI
Thierry GALLI
SNARE [soluble NSF ( N -ethylmaleimide-sensitive factor) attachment protein receptor] proteins are essential for membrane fusion but their regulation is not yet fully understood. We have previously shown that the amino-terminal Longin domain of the v-SNARE TI-VAMP (tetanus neurotoxin-insensitive vesicle-associated membrane protein)/VAMP7 plays an inhibitory role in neurite outgrowth. The goal of this study was to investigate the regulation of TI-VAMP as a model of v-SNARE regulation. We show here that the Longin domain (LD) plays a dual role. First, it negatively regulates the ability of TI-VAMP and of a Longin/Synaptobrevin chimera to participate in SNARE complexes. Second, it interacts with the adaptor complex AP-3 and this interaction targets TI-VAMP to late endosomes. Accordingly, in mocha cells lacking AP-3δ, TI-VAMP is retained in an early endosomal compartment. Furthermore, TI-VAMPc, an isoform of TI-VAMP lacking part of the LD, does not interact with AP-3, and therefore is not targeted to late endosomes; however, this shorter LD still inhibits SNARE-complex formation. These findings support a mechanism controlling both localization and function of TI-VAMP through the LD and clathrin adaptors. Moreover, they point to the amino-terminal domains of SNARE proteins as multifunctional modules responsible for the fine tuning of SNARE function.

1 December 2004 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
VRV Rossi
V Rossi
DBD Banfield
D Banfield
MVM Vacca
M Vacca
LDL Dietrich
L Dietrich
CUC Ungermann
C Ungermann
FFFrancesco Filippini
Francesco Filippini

1 February 1996 in Nature
Verified
Journal Article
Closed access
FFFrancesco Filippini
Francesco Filippini
VRValeria Rossi
Valeria Rossi
OMOriano Marin
Oriano Marin
MTMaurizio Trovato
Maurizio Trovato
Paolo CostantinoPaolo Costantino
Paolo Costantino
MTMario Terzi
Mario Terzi

18 July 2006 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
Sandro VivonaSandro Vivona
Sandro Vivona
FBFilippo Bernante
Filippo Bernante
FFFrancesco Filippini
Francesco Filippini
Background: Since a milestone work on Neisseria meningitidis B, Reverse Vaccinology has strongly enhanced the identification of vaccine candidates by replacing several experimental tasks using in silico prediction steps. These steps have allowed scientists to face the selection of antigens from the predicted proteome of pathogens, for which cell culture is difficult or impossible, saving time and money. However, this good example of bioinformatics-driven immunology can be further developed by improving in silico steps and implementing biologist-friendly tools. Results: We introduce NERVE (New Enhanced Reverse Vaccinology Environment), an user-friendly software environment for the in silico identification of the best vaccine candidates from whole proteomes of bacterial pathogens. The software integrates multiple robust and well-known algorithms for protein analysis and comparison. Vaccine candidates are ranked and presented in a html table showing relevant information and links to corresponding primary data. Information concerning all proteins of the analyzed proteome is not deleted along selection steps but rather flows into an SQL database for further mining and analyses. Conclusion: After learning from recent years' works in this field and analysing a large dataset, NERVE has been implemented and tuned as the first available tool able to rank a restricted pool (~8–9% of the whole proteome) of vaccine candidates and to show high recall (~75–80%) of known protective antigens. These vaccine candidates are required to be "safe" (taking into account autoimmunity risk) and "easy" for further experimental, high-throughput screening (avoiding possibly not soluble antigens). NERVE is expected to help save time and money in vaccine design and is available as an additional file with this manuscript; updated versions will be available at http://www.bio.unipd.it/molbinfo.

1 July 2001 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
FFFrancesco Filippini
Francesco Filippini
VRValeria Rossi
Valeria Rossi
Thierry GALLIThierry GALLI
Thierry GALLI
ABAlberta Budillon
Alberta Budillon
MDMichele D'URso
Michele D'URso
MDMaurizio D'ESposito
Maurizio D'ESposito

5 February 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
PBPietro Bellet
Pietro Bellet
MGMatteo Gasparotto
Matteo Gasparotto
SPSamuel Pressi
Samuel Pressi
AFAnna Fortunato
Anna Fortunato
GSGiorgia Scapin
Giorgia Scapin
FFFrancesco Filippini
Francesco Filippini
Leading-edge regenerative medicine can take advantage of improved knowledge of key roles played, both in stem cell fate determination and in cell growth/differentiation, by mechano-transduction and other physicochemical stimuli from the tissue environment. This prompted advanced nanomaterials research to provide tissue engineers with next-generation scaffolds consisting of smart nanocomposites and/or hydrogels with nanofillers, where balanced combinations of specific matrices and nanomaterials can mediate and finely tune such stimuli and cues. In this review, we focus on graphene-based nanomaterials as, in addition to modulating nanotopography, elastic modulus and viscoelastic features of the scaffold, they can also regulate its conductivity. This feature is crucial to the determination and differentiation of some cell lineages and is of special interest to neural regenerative medicine. Hereafter we depict relevant properties of such nanofillers, illustrate how problems related to their eventual cytotoxicity are solved via enhanced synthesis, purification and derivatization protocols, and finally provide examples of successful applications in regenerative medicine on a number of tissues.